3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
11
Colorectal Neoplasms
10
Neoplasm Metastasis
6
Rhabdomyosarcoma
3
Neuroblastoma
3
Lung Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Ewing
2
Sarcoma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Neuroendocrine
2
Biliary Tract Neoplasms
2
Uterine Cervical Neoplasms
1
Solid Tumors
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Refractory Solid Tumors
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Medulloblastoma
1
Malignant mesenchymal tumor
1
Intestinal Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
4
Specimen Handling
3
Biopsy
3
sodium-iodide symporter
2
fludarabine
2
cemiplimab
2
X-Rays
2
Whole-Body Irradiation
2
Stem Cell Transplantation
2
Photons
2
Nivolumab
2
Mycophenolic Acid
2
Immunoglobulin G
2
Disulfides
2
Cyclosporine
2
treosulfan
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
entrectinib
1
duvelisib
1
alectinib
1
Vinblastine
1
Tacrolimus
1
Standard of Care
1
Sirolimus
1
Practice Guidelines as Topic
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large-Cell, Anaplastic
×
Irinotecan
×
30 days
×
Clear all
No trials found.